Rebecca Williams, MD
Obstetrics & Gynecology · Lawrenceville, GANPI 1508040353
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,618 of the $17,292 with a category attached, or 73.0%. Astellas Pharma US Inc accounts for 92.3% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $14,368 and has fallen 89.3% since, to $1,531 in 2025. Among obstetrics & gynecology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $266.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$16K
- Coopersurgical, Inc.$322
- AbbVie$156
- Mayne Pharma Commercial LLC$136
- Optumhealth Care Solutions, LLC$112
- Baxter Healthcare$98
- plus $501 from 18 others
What the payments were for
- Consulting fees$2,96517%
- Speaking & faculty fees$12,61873%
- Food & beverage$1,5989%
- Education$1121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 16 | $15,968 |
| Coopersurgical, Inc. | 11 | $322 |
| AbbVie(2 entities) | 5 | $156 |
| Mayne Pharma Commercial LLC | 3 | $136 |
| Optumhealth Care Solutions, LLC | 4 | $112 |
| Baxter Healthcare | 1 | $98 |
| Hologic Sales And Service, LLC | 4 | $68 |
| Johnson & Johnson | 3 | $58 |
| Organon | 2 | $56 |
| Applied Medical Resources Corporation | 1 | $55 |
| Davol Inc. | 1 | $44 |
| Aspira Women's Health Inc | 2 | $24 |
| Biogen | 1 | $23 |
| Pfizer | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Millicent US Inc | 1 | $15 |
| Merck | 1 | $13 |
| Amgen | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$12,222
- Paragard$124
- NEXTSTELLIS$118
How this compares
$17,292 in reported general payments places this provider in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 11 | $975 |
| Estradiol | 13 | $899 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Lawrenceville
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
- Teresa ByrdMarietta$41K
- Christopher BassilSuwanee$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.